Invitation to a webcast: adapting and acting in response to the Covid-19 crisis April 20, 2020 April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin April 6, 2020 April 6, 2020
BEPO®: Bioresorbable diblock mPEG-PDLLA and triblock PDLLA-PEG- PDLLA based in situ forming depots with flexible drug delivery kinetics modulation March 10, 2020 March 10, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell January 28, 2020 January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020 January 13, 2020 January 13, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019) December 3, 2019 December 3, 2019
